Navigation Links
Third European Novel Food Approval Received by Tahitian Noni International
Date:4/28/2010

Outnumbered only by Unilever, TNI and Danone share the leading position in the European Union’s “Novel Foods” category

Provo, UT (Vocus) April 28, 2010 -- Tahitian Noni International (TNI) received the company’s third Novel Food approval from the European Commission on Food Safety. Now, not only do noni juice and noni leaf have Novel Food approval, but also noni concentrates and noni puree have authorization to be sold within the European Union. In terms of the total number of Novel Food approvals, Tahitian Noni International shares an equal number with Danone and is outnumbered only by the five individual approvals granted to the Unilever Group.

Committed to Science and Quality from Day One
Approval procedures for Novel Foods take time, money, and require significant scientific research assuring the safety of the product in question. It is not uncommon for an application to take five years or more being reviewed, before approval is granted.

Kevin Asay, Tahitian Noni International’s Managing Director in charge of Regulatory Affairs and Quality Assurance, says: “14 years after the founding of our company, we are in a position to compete with Danone in the category of approved Novel Food applications. We take pride in this achievement and are confident that it stems from our commitment to science and quality from day one.”

Noni is now a Full-Fledged Novel Food
With this third approval, Tahitian Noni International now holds Novel Food approval for all food categories relevant to their wide variety of products. In 2003, the first approval was issued for the use of noni juice as a novel food ingredient in Tahitian Noni™ Original, then marketed as Tahitian Noni™ Juice in Europe. This approval was followed in 2008 by the authorization of noni leaves as a novel food ingredient for the preparation of other products, including tea. This latest approval now gives Tahitian Noni International the ability to use noni concentrates and noni puree in products as well.

Currently, Tahitian Noni International is focused on the worldwide product launch of its new product line of Tahitian Noni® Bioactive Beverages™ introduced in the USA at the end of February 2010. A graduated launch in Europe is scheduled to start at the end of May 2010.

About the Company
Tahitian Noni International is a global, research-driven bioactive products company that was the first to introduce the health benefits of the noni plant—a bioactive-rich, adaptogenic plant, containing iridoid compounds—to the world outside of Tahiti. Tahitian Noni International is the leader in the discovery, development, manufacturing, and marketing of noni-based bioactive products including beverages, beauty, and weight loss lines. Tahitian Noni International has a presence in over 70 markets worldwide, and is the world-wide leader in bioactive beverages.

Contact:
Andre Peterson
Director, Public Relations
(801) 234-1401

# # #

Read the full story at http://www.prweb.com/releases/2010/Novel_food_approval/prweb3934514.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. SIS Rules-Based Charging Solution Successfully Peer Reviewed by HFMA for Third Consecutive Year
2. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010
3. Anthem Blue Cross Wins Third Largest Medicaid Managed Care Contract Renewal in the Country
4. Tipping Point Community Announces $1 Million Gift at Third Annual Awards Breakfast
5. China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009
6. Almost two-thirds of pregnant women believe they are regularly exposed to physical risk at work
7. Two-Thirds of American Teens Need More Shut-Eye
8. Study Finds More Than One Third of Parents Experience Traumatic Stress One Month After Childs Injury
9. New Program Provides COBRA Relief for Third Party Administrators
10. Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results
11. New Study Shows Nearly One Third of Overweight Adolescents See Themselves as Underweight or About Right
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Third European Novel Food Approval Received by Tahitian Noni International 
(Date:1/20/2017)... ... 20, 2017 , ... “Code Word: Chocolate Biscuit”: a biographical account following a man who went ... creation of published author, Marlyn Ivey, born in Lynn Haven, Florida and at the age ... at 19 years of age, he joined the Navy and got married right out of ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Knowledge is God’s Lighthouse”: ... by faith. “Knowledge is God’s Lighthouse” is the creation of published author, Gene Gaapf, ... and poetry collections. , “I have been writing since high school and have ...
(Date:1/19/2017)... ... , ... Next week after January 20th, the fear for many is that ... health needs of over 30 million. Many interviews with Dr. Carol Francis at the ... servants were suppose to prioritize. Interviews provided below. , Among those present ...
(Date:1/19/2017)... ... 2017 , ... WhoHaha , a digital media company dedicated to creating ... to produce a three-part video series that uses humor to highlight ways to improve ... of AHA’s Healthy For Good™ movement, which is designed to inspire all Americans to ...
(Date:1/19/2017)... Scotch Plains, NJ (PRWEB) , ... January 19, ... ... a board certified dermatologist by the American Board of Dermatology and fellowship trained ... Institute of the National Institutes of Health, Dr. Li completed his internship in ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... , Jan. 20, 2017  Ethicon ... acquired Megadyne Medical Products, Inc., a privately ... and markets electrosurgical tools used in operating ... intelligence of Ethicon,s* advanced energy devices with ... a major step forward in Ethicon,s goal ...
(Date:1/20/2017)... , Jan. 20, 2017  Palladian Health, a ... announced the launch of an opioid management program ... on opioids and helps stem the growing tide ... prescribed to treat chronic non-cancer pain (back pain, ... risks and lack of evidence regarding long-term effectiveness. ...
(Date:1/20/2017)... , January 20, 2017 Avillion LLP, ... appointment of Mark Weinberg , MD MBA as Chief Medical ... , USA . ... Dr Weinberg has spent more than 17 years ... 20" pharma companies to micro-cap biotech. Over the course of his ...
Breaking Medicine Technology: